Google Translate Limitations Disclaimer

The electronic translation service on the brainXchange website is hosted by Google Translate, an external translation service. The brainXchange does not guarantee or warrant the reliability, accuracy or completeness of any translated information. The basic translation goal is to capture the general information of the original English website content. If any questions arise related to the accuracy of the information contained in the translated website, please refer to the English version of the website.

Home > Events > Archived Webinars & Events > 2024 > Interplay of Mood and Cognition in Late Life

Interplay of Mood and Cognition in Late Life

Event Date: Jan 16, 2024

Recording | Related Resources

In this webinar we will discuss the complex interplay of mood and cognition in late life. How mood disorder can impact risk of developing dementia, and its diagnosis, and risk of depression in those with existing cognitive disorder. We will also touch on challenges in assessment and management of depression in the context of cognitive disorders.

This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium on Neurodegeneration in Aging (CCNA).

Presenter(s):

Dr. Sanjeev Kumar, Scientist, Psychiatrist and Medical Head, Adult Neurodevelopment and Geriatric Psychiatry Division at CAMH, Associate Professor, University of Toronto.

Dr. Sanjeev Kumar is a geriatric psychiatrist and the Medical Head of Geriatric Research at the Centre for Addiction and Mental Health (CAMH), Toronto, Canada. He is an associate professor of psychiatry at the University of Toronto. Dr. Kumar’s research focuses on developing novel biomarkers and treatment interventions for patients with Alzheimer’s disease (AD). He is studying novel neurophysiological markers underlying cognitive and behavioral symptoms of AD using transcranial magnetic stimulation (TMS), electroencephalography (EEG) and brain imaging techniques. He is also exploring the role of novel treatment interventions such as TMS and transcranial direct current stimulation (tDCS) to treat cognitive and behavioral symptoms of AD.